Paul Levine

Affiliations: 
2014- Chemistry Tufts University, Boston 
Google:
"Paul Levine"
Mean distance: 8.75
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liu S, Daley EJ, Tran LM, et al. (2024) Backbone Modification Provides a Long-Acting Inverse Agonist of Pathogenic, Constitutively Active PTH1R Variants. Journal of the American Chemical Society
Levine PM, Craven TW, Li X, et al. (2022) Generation of Potent and Stable GLP-1 Analogues Via "Serine Ligation". Acs Chemical Biology
Balana AT, Levine PM, Craven TW, et al. (2021) O-GlcNAc modification of small heat shock proteins enhances their anti-amyloid chaperone activity. Nature Chemistry
Levine PM, Balana AJ, Sturchler E, et al. (2019) O-GlcNAc engineering of GPCR peptide-agonists improves their stability and in vivo activity. Journal of the American Chemical Society
Levine PM, Galesic A, Balana AT, et al. (2019) α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America
Levine PM, Pratt MR. (2018) Revolutionizing Our Understanding of Amyloidogenic Proteins by Cryo-Electron Microscopy. Biochemistry
De Leon CA, Levine PM, Craven TW, et al. (2017) The sulfur-linked analog of O-GlcNAc (S-GlcNAc) is an enzymatically stable and a reasonable structural-surrogate for O-GlcNAc at the peptide and protein levels. Biochemistry
Levine PM, De Leon CA, Galesic A, et al. (2017) O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein. Bioorganic & Medicinal Chemistry
Lewis YE, Galesic A, Levine PM, et al. (2017) O-GlcNAcylation of α-synuclein at serine 87 reduces aggregation without affecting membrane binding. Acs Chemical Biology
See more...